Journal article · Pediatric← The news desk

✦ The Dispatch

Ototoxicity Associated with Antineoplastic Agents in the Pediatric Population: An Evidence-Based Review of Auditory Monitoring Strategies and Contemporary Diagnostic Frameworks-Narrative Review

A dispatch from PubMed — filed

Ototoxicity represents a clinically significant complication of anticancer therapy in pediatric patients. Cytotoxic agents used in oncology, particularly platinum-based chemotherapy, may induce damage to the auditory and vestibular systems, resulting in hearing loss, tinnitus, and balance disturbances....

Clinical Takeaway

Audiologists managing pediatric oncology patients should apply evidence-based auditory monitoring protocols aligned with current diagnostic frameworks for platinum-based chemotherapy ototoxicity; this review consolidates existing guidance but does not introduce new practice-changing evidence.

Why It Matters

Pediatric ototoxicity monitoring is an underserved area where standardised protocols can meaningfully reduce permanent hearing loss in childhood cancer survivors.

Key Points
  1. 01Platinum-based chemotherapy (e.g., cisplatin, carboplatin) is a leading cause of permanent hearing loss in pediatric oncology patients.
  2. 02The review evaluates current auditory monitoring strategies including high-frequency audiometry and OAE testing.
  3. 03Contemporary diagnostic frameworks such as SIOP and ASHA grading scales are compared.
  4. 04Early detection through serial audiological monitoring is emphasised to enable timely intervention.
  5. 05Gaps in standardisation of monitoring schedules across institutions are identified.
Claims & Evidence

Platinum-based chemotherapy causes ototoxicity (hearing damage) in pediatric oncology patients.

studysupported

Evidence-based auditory monitoring strategies can facilitate early detection of chemotherapy-induced hearing loss in children.

guidelinesupported
Research metadata
PMID
42121973
DOI
10.3390/diagnostics16091272.
Journal
Diagnostics
Publication type
review
Evidence level
5
Population
Pediatric oncology patients receiving antineoplastic (cancer-fighting) agents, particularly platinum-based chemotherapy
Intervention
Auditory monitoring strategies and diagnostic frameworks for ototoxicity surveillance

Primary outcomes

Evaluation of auditory monitoring strategies for ototoxicity detection; Comparison of contemporary diagnostic frameworks for hearing loss classification

Related stories